NEW YORK (GenomeWeb News) — European Union regulators have cleared an Abbott assay that uses real-time PCR to monitor hepatitis B viral loads, Abbott and partner Celera Diagnostics said yesterday.
The certification allows the companies to market the test in the EU. The test runs on Abbott’s m2000 instrument, which uses PCR technology made by Applied Biosystems.
The m2000 also runs PCR tests for HIV-1, hepatitis C, chlamydia, and a combination test for chlamydia or gonorrhea.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.